These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9103145)

  • 1. Cost-effectiveness of interferon-alpha as maintenance therapy in chronic myelogenous leukemia.
    Messori A; Becagli P; Trippoli S
    Ann Intern Med; 1997 Apr; 126(8):664-5. PubMed ID: 9103145
    [No Abstract]   [Full Text] [Related]  

  • 2. Is imatinib a cost-effective treatment for newly diagnosed chronic myeloid leukemia patients?
    Goldman J
    Nat Clin Pract Oncol; 2005 Mar; 2(3):126-7. PubMed ID: 16264901
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost-effectiveness of interferon-alpha and conventional chemotherapy in chronic myelogenous leukemia.
    Kattan MW; Inoue Y; Giles FJ; Talpaz M; Ozer H; Guilhot F; Zuffa E; Huber SL; Beck JR
    Ann Intern Med; 1996 Oct; 125(7):541-8. PubMed ID: 8815752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of interferon-alpha for chronic myeloid leukemia.
    Goldman JM
    Ann Oncol; 1998 Apr; 9(4):351-2. PubMed ID: 9636823
    [No Abstract]   [Full Text] [Related]  

  • 5. Imatinib mesylate--a new oral targeted therapy.
    Savage DG; Antman KH
    N Engl J Med; 2002 Feb; 346(9):683-93. PubMed ID: 11870247
    [No Abstract]   [Full Text] [Related]  

  • 6. Cost effectiveness of imatinib compared with interferon-alpha or hydroxycarbamide for first-line treatment of chronic myeloid leukaemia.
    Dalziel K; Round A; Garside R; Stein K
    Pharmacoeconomics; 2005; 23(5):515-26. PubMed ID: 15896102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of imatinib versus interferon-alpha plus low-dose cytarabine for patients with newly diagnosed chronic-phase chronic myeloid leukemia.
    Reed SD; Anstrom KJ; Ludmer JA; Glendenning GA; Schulman KA
    Cancer; 2004 Dec; 101(11):2574-83. PubMed ID: 15493042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effectiveness of treatment with native alpha-interferon (Wellferon) in patients with chronic myeloid leukemia].
    Rukavitsyn OA
    Vopr Onkol; 1997; 43(6):606-9. PubMed ID: 9479361
    [No Abstract]   [Full Text] [Related]  

  • 9. Juvenile chronic myelogenous leukemia: therapeutic trial with interferon alpha 2B.
    Agarwal BR; Gulvady A; Joshi K; Khemani S; Currimbhoy ZE
    Indian Pediatr; 1995 Sep; 32(9):1002-4. PubMed ID: 8935266
    [No Abstract]   [Full Text] [Related]  

  • 10. [Drug treatment of chronic myeloid leukemia: a cost effectiveness analysis of first- and second-line treatment ].
    Groot MT; Ossenkoppele GJ; Kramer MH; van den Boom G; Huijgens PC; Uyl-de Groot CA
    Ned Tijdschr Geneeskd; 2003 Jul; 147(30):1460-5. PubMed ID: 12908349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effectiveness of interferon-alpha therapy in Ph-positive chronic myeloid leukemia].
    Bogdanov KV; Frolova OI; Marinets OV; Ogorodnikova IuS; Afanas'ev BV; Zaritskiĭ AIu
    Vopr Onkol; 2003; 49(2):189-92. PubMed ID: 12785203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there still a role for interferon-alpha for newly diagnosed chronic myeloid leukemia in chronic phase?
    Quintás-Cardama A; Verstovsek S
    Leuk Lymphoma; 2007 Mar; 48(3):445-6. PubMed ID: 17454579
    [No Abstract]   [Full Text] [Related]  

  • 13. Interferon-alpha lymphoblastoid in chronic myeloid leukemia patients unresponsive to recombinant IFN alpha 2.
    Steegmann JL; Granados E; Peñarrubia MJ
    Haematologica; 1997; 82(6):731-2. PubMed ID: 9580090
    [No Abstract]   [Full Text] [Related]  

  • 14. Cost-effectiveness of interferon alfa in chronic myelogenous leukemia.
    Liberato NL; Quaglini S; Barosi G
    J Clin Oncol; 1997 Jul; 15(7):2673-82. PubMed ID: 9215840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment with interferon alpha of the lymphoblastic transformation of chronic myeloid leukemia].
    Canales MA; Martínez J; Quevedo E; Hernández-Navarro F
    Sangre (Barc); 1999 Dec; 44(6):493-4. PubMed ID: 10822770
    [No Abstract]   [Full Text] [Related]  

  • 16. Interferon-alpha: mechanisms of action in chronic myelogenous leukemia in chronic phase.
    Guilhot F; Lacotte-Thierry L
    Hematol Cell Ther; 1998 Oct; 40(5):237-9. PubMed ID: 9844819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The M.D. Anderson Cancer Center experience with interferon-alpha therapy in chronic myelogenous leukaemia.
    Talpaz M; Kantarjian HM; O'Brien S; Kurzrock R
    Baillieres Clin Haematol; 1997 Jun; 10(2):291-305. PubMed ID: 9376665
    [No Abstract]   [Full Text] [Related]  

  • 18. Pregnancy in chronic myeloid leukemia patients treated with alpha interferon.
    Al Bahar S; Pandita R; Nath SV
    Int J Gynaecol Obstet; 2004 Jun; 85(3):281-2. PubMed ID: 15145269
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful pregnancy occurring with interferon-alpha therapy in chronic myeloid leukemia.
    Mesquita MM; Pestana A; Mota A
    Acta Obstet Gynecol Scand; 2005 Mar; 84(3):300-1. PubMed ID: 15715542
    [No Abstract]   [Full Text] [Related]  

  • 20. Complete molecular remission in chronic myelogenous leukemia after imatinib therapy.
    Barbany G; Höglund M; Simonsson B;
    N Engl J Med; 2002 Aug; 347(7):539-40. PubMed ID: 12181416
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.